Aspen and Biovac to bid for vaccine contracts under new $1bn Africa package
Decision to create an African vaccine-making accelerator is the culmination of an AU campaign to reduce the risk of another jabs shortage
Global vaccine alliance Gavi has announced a $1bn package to support African vaccine manufacturers, a move expected to boost JSE-listen Aspen Pharmacare and state-backed Biovac.
Gavi’s decision to create the African Vaccine Manufacturing Accelerator (AVMA) is the culmination of a long-running campaign by the AU to reduce the risk of member nations being last in line when jabs are in short supply, as they were during the Covid-19 pandemic...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.